Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 5Neoplasms, Plasma Cell 3Neoplasms 3Multiple Myeloma 2Lymphoma 2Leukemia 2Infections 2Hematologic Neoplasms 2Urologic Neoplasms 1Neuromyelitis Optica 1Neuroblastoma 1Myelitis, Transverse 1Melanoma 1Lymphoma, Non-Hodgkin 1Limbic Encephalitis 1Immunoglobulin Light-chain Amyloidosis 1Epilepsy 1Epilepsies, Partial 1Drug Resistant Epilepsy 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Autoimmune Diseases of the Nervous System 1Autoimmune Diseases 1

Interventions

telitacicept 3fludarabine 3Prednisone 3Data Collection 3Cyclophosphamide 3Specimen Handling 2Nivolumab 2Blood Specimen Collection 2Antilymphocyte Serum 2thymoglobulin 1remdesivir 1prednylidene 1human papillomavirus vaccine, L1 type 16, 18 1deltacortene 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1apremilast 1Watchful Waiting 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Platinum Compounds 1Plasma Exchange 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases × Immunoglobulins, Intravenous × Clear all
NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Emory University

Phase 2 Terminated
20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡